PS
IBBQ icon

Principal Securities’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Principal Securities’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-965
Closed -$23.5K – 2343
2025
Q3 		$23.5K Hold
965
– – ﹤0.01% 2340
2025
Q2 		$20.4K Hold
965
– – ﹤0.01% 2302
2025
Q1 		$20.8K Hold
965
– – ﹤0.01% 2179
2024
Q4 		$20.8K Hold
965
– – ﹤0.01% 2175
2024
Q3 		$22.9K Buy
+965
New +$23K ﹤0.01% 2050

Other funds holding IBBQ

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $77.5M AUM
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Principal Securities's IBBQ Position: Q4 2025 in Review

Principal Securities sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q4 2025, closing a stake of 965 shares — an estimated $23.5K sold.

Principal Securities first reported a position in IBBQ in Q3 2024 and held it in 5 quarters. The position peaked at $23.5K in Q3 2025. 31 funds tracked by Wall St. Rank hold IBBQ as of Q4 2025.

  • Principal Securities reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 965 Invesco NASDAQ Biotechnology ETF shares in Q4 2025, an estimated $23.5K.
  • Principal Securities first reported a position in Invesco NASDAQ Biotechnology ETF in Q3 2024 and held it in 5 quarters.
  • Principal Securities's Invesco NASDAQ Biotechnology ETF position peaked at $23.5K in Q3 2025.
  • 31 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.